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Abstract 
Chronic ACTH exposure  is associated with adrenal hypertrophy and steroidogenesis. The 
underlying molecular processes in mice have been analysed by microarray, histological and 
immunohistochemical techniques. Synacthen infused for 2weeks markedly increased adrenal 
mass and plasma corticosterone levels. Microarray analysis found greater than 2-fold changes 
in expression of 928 genes (P<0.001; 397 up, 531 down). These clustered in pathways 
involved in signalling, sterol/lipid metabolism, cell proliferation/hypertrophy and apoptosis. 
Signalling genes included some implicated in adrenal adenomas but also upregulated genes 
associated with cyclic AMP and downregulated genes associated with aldosterone synthesis. 
Sterol metabolism genes were those promoting cholesterol supply (Scarb1, Sqle, Apoa1) and 
disposal (Cyp27a1, Cyp7b1). Oil red O staining showed lipid depletion consistent with 
reduced expression of genes involved in lipid synthesis. Genes involved in steroidogenesis 
(Star, Cyp11a1, Cyp11b1) were modestly affected (P<0.05; < 1.3-fold). Increased Ki67, 
Ccna2, Ccnb2, Tk1 expression complemented immunohistochemical evidence of a 3-fold 
change in cell proliferation. Growth arrest genes, Cdkn1a and Cdkn1c, which are known to be 
active in hypertrophied cells, were increased > 4-fold and cross-sectional area of fasciculata 
cells was 2-fold greater. In contrast, genes associated with apoptosis (eg Casp12, Clu,) were 
down-regulated and apoptotic cells (Tunel staining) were fewer (P <0.001) and more widely 
distributed throughout the cortex. 
In summary, long term steroidogenesis with ACTH excess is sustained by genes controlling 
cholesterol supply and adrenal mass. ACTH effects on adrenal morphology and genes 
controlling cell hypertrophy, proliferation and apoptosis suggest the involvement of different 
cell types and separate molecular pathways.  
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Introduction 
Temporal control of adrenocortical responses to ACTH involves several processes, mediated 
by a common signalling system. In vivo and in vitro studies show that within five minutes, 
stress and ACTH cause increased adrenal corticosteroid release (Pearlmutter, et al. 1973; 
Walker, et al. 2015). Closer analysis of acute responses has demonstrated that activation of 
melanocortin receptors trigger cyclic AMP synthesis, leading to the synthesis of StaR which 
promotes the uptake of cholesterol into mitochondria (Artemenko, et al. 2001; Clark 2016; 
Simpson and Waterman 1983). Since steroid hormones are synthesised on demand, the 
availability of intramitochondrial cholesterol initiates steroidogenesis by providing substrate 
for the first rate-limiting enzyme in the steroidogenic pathway (Miller and Bose 2011). Long-
term exposure to ACTH, requires changes in cholesterol supplysteroidogenic enzyme 
expression and adrenocortical cell hypertrophy and hyperplasia which take place over hours, 
days and weeks to maintain steroid output at a continuous high level. Although many of these 
key processes involve non-genomic enzyme activation, transcriptional control is also 
important. 
Long term supply of cholesterol substrate is maintained by de novo synthesis, by uptake from 
the circulation and by release from stored intracellular lipid droplets. Key steps in de novo 
synthesis are hydroxymethyglutaryl CoA reductase (Hmgcr), squalene epoxidase (Sqle) and 
various post-lanosterol reductase and dehydrogenase steps (Ness 2015). Plasma LDL and 
HDL cholesterol (Brown, et al. 1979; Gwynne and Strauss 1982) are also available for 
steroidogenesis via LDL (Ldlr) and scavenger receptor (Scarb1) respectively.   Within the 
adrenal cortex, cholesterol is stored as an ester in lipid droplets or utilized for steroidogenesis 
depending on the balance between lipase and esterifying enzyme activity (Beckett and Boyd 
1977; Kraemer 2007; Thorngate, et al. 2002) 
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Although prolonged stress or ACTH treatment causes adrenal gland hypertrophy, effects on 
the expression of genes encoding steroidogenic enzymes are less profound (Lehoux, et al. 
1998; Ye, et al. 2008). In fact, it may be that induction of intra-adrenal steroid hormone 
metabolising enzymes help mitigate the effects of excess ACTH. In sheep, for example, there 
is a marked increase in 20 hydroxylation of corticosteroid intermediates which have no 
clearly defined biological activity (Butkus, et al. 1985). Similarly, there are reports that 
adrenal 5α reductase and sulfotransferase activities may affect the secretion of biologically 
active hormones (Al-Dujaili, et al. 2011; Luu-The, et al. 2005).  
Genomic and somatic mutations of various genes have been identified that explain excess 
steroid production in cortisol and aldosterone producing adenomas (Calebiro, et al. 2015; 
Zennaro, et al. 2015). These involve gain/loss of function that affect adrenocortical signalling 
processes. Although these genes are required, physiological control of steroidogenesis is not 
necessarily mediated by regulation of their expression. Moreover, there is a need to determine 
that signalling elements responsible for acute changes in steroid output are the same as those 
mediating adrenocortical adaptation to chronic stress or prolonged ACTH exposure.  
 
In this study, we have used microarray analysis of mouse adrenal tissue to gain a 
comprehensive picture of transcriptional control processes affecting cell signalling, 
cholesterol supply and cell turnover in response to chronic stimulation of corticosterone 
synthesis in mice infused with an ACTH analogue, Synacthen. We found modest changes in 
genes encoding steroidogenic enzymes. Our data suggests that enhanced steroidogenic 
capacity reflects increases in cell size and a shift in the balance between proliferation and 
apoptosis that increases cell number. Sterol/lipid metabolic pathways are also changed in 
several ways to allow cholesterol to be channelled towards steroidogenesis.  
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Materials & Methods 
All experiments involving animals were approved by the University of Edinburgh Animal 
Welfare and Ethical Review Body and were carried out in strict accord with accepted 
standards of humane animal care under the auspices of the Animal (Scientific Procedures) 
Act UK 1986. Groups (n =5/6) of age-matched male C57BL6 mice (Harlan Olac) weighing 
approximately 25g were fed a diet containing 0.3% Na (SDS Diets, Witham, Essex, UK) with 
free access to water in a temperature and light-controlled (12h light/dark cycle; 07.00h lights 
on) room. Mice were infused sc via miniosmotic infusion pumps (Alzet Cupertino, Model 
2002) with either vehicle (0.154M NaCl) or ACTH (Synacthen Ciba-Geigy, UK; 3µg/d). At 
the end of the study mice were killed by carbon dioxide at the nadir of the circadian cycle. 
Pairs of adrenal glands were collected into a solution of RNeasy (Qiagen Ltd, Crawley, UK). 
Each adrenal was carefully trimmed free of fat under a dissecting microscope and weighed. 
 
Histology and immunohistochemistry. 
Additional groups of mice were infused with ACTH or saline as above to assess effects on 
adrenal morphology and cell proliferation. Blood was collected by cardiac puncture into 
lithium heparin tubes for corticosterone measurements by ELISA (Al-Dujaili, et al. 2009). In 
one experimental cohort, bromodeoxyuridine (1mg/ml) was added to the minipump infusates 
to monitor cell proliferation.  After a two-week infusion, mice were killed by decapitation 
and tissues collected for fixation in buffered formalin and embedded in paraffin wax. BrdU 
positive and Ki67 positive nuclei in mid-adrenal sections were located by 
immunohistochemistry as previously described (Chang, et al. 2013). Cells with Ki67 positive 
nuclei were counted in the zona glomerulosa/outer zona fasciculata region of the cortex and 
numbers were normalised to length of capsule perimeter. Haematoxylin and eosin stained 
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sections were used to estimate cell size in different regions of the adrenal cortex (Chang et al. 
2013).  
To assess the cellular storage of cholesterol, adrenals were collected without fixation and 
stored at -80C before cryosectioning for oil red O staining of lipid droplets. Images were 
captured with a Niko Coolpix color camera with a Zeiss Axioskop 2 compound microscope 
and MCID imaging software (Imaging Research Inc, St Catharines, Ontario, Canada) 
Apoptosis was analysed using a Roche Tunel staining kit (Sigma-Aldrich, UK). 
 
Microarray processing 
RNA for microarray analysis was prepared from individual adrenal glands (n = 5 and 6 for 
saline and ACTH-treated mice respectively) using TRIzol® (ThermoFisher Scientific, 
Loughborough, UK) and then processed through standard Affymetrix protocols, with one 
round of cDNA amplification (Dunbar, et al. 2010). Processed RNAs from individual adrenal 
glands were hybridised to Affymetrix Mouse Genome 430 2.0 GeneChip. RNA processing 
and microarray analyses were carried out by Ark Genomics (Roslin, Edinburgh). Data were 
analysed as previously described (Dunbar et al. 2010). Microarray data have been archived in 
the ArrayExpress data repository with the accession number E-MTAB-5704 . Differentially 
regulated transcripts were analysed with DAVID Bioinformatic Resources (Huang da, et al. 
2009) Cluster analysis of genes involved in signalling, sterol and lipid metabolism and cell 
turnover was carried out with Miru software (Freeman, et al. 2007). Genes of interest that are 
discussed are listed in supplementary Table 1. 
 
Real time RTPCR 
Based on initial findings from microarrays, selected genes were quantified by pre-optimised 
RT-PCR assays in RNA from individual adrenals of separate cohorts of saline and ACTH-
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treated mice that were killed with CO2 Total RNA was extracted from tissue samples using 
the Qiagen RNeasy system and reverse transcribed into cDNA with random primers using the 
QuantiTect DNase / reverse transcription kit (Qiagen Ltd).  cDNA (equivalent to 1ng total 
RNA) was incubated in triplicate with gene specific primers and fluorescent probes (using 
pre-designed assays from Applied Biosystems, Warrington, UK) in 1x Roche 
LightCyclerR480 Probes mastermix. PCR cycling and detection of fluorescent signal was 
carried out using a Roche LightCyclerR480. A standard curve was constructed for each 
primer probe set using a serial dilution of cDNA pooled from all samples. Results were 
corrected for the mean of expression of beta-actin and 18S ribosomal RNA. Neither 18S 
RNA nor beta actin were affected by ACTH treatment. 
Statistics  
Data are presented as mean ± SE. After tests for Gaussian distribution, comparisons were 
made using either unpaired t-test or ANOVA with Bonferroni post hoc testing; P ≤ 0.05 were 
considered statistically significant. Gene expression profiles with Pearson correlation 
coefficients ≥ 0.9 were analysed for clustering. 
 
Results 
Adrenal response to ACTH treatment 
Mice infused with ACTH had larger adrenals and higher plasma corticosterone levels (Figure 
1A & B). Previous studies of urinary corticosterone excretion in this model indicate that 
ACTH treatment produces a sustained increase in steroidogenesis (Dunbar et al. 2010). Body 
weight gain was not affected. After normalisation and correction for multiple testing, 
microarray analysis indicated that ACTH significantly affected the expression of 
approximately 9000 gene transcripts (P <0.05; figure 1C); 397 and 531 annotated genes were 
up- and down-regulated respectively by ≥ two-fold (P < 0.001). To validate the microarray 
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results, a parallel analysis was carried out using PCR methods to quantify mRNA of 
representative genes that were up- and down-regulated in the microarray. The choice of genes 
reflected a range of responses and their possible involvement in processes controlling 
signalling and sterol metabolism (Lpl, Srd5a1, Scarb1, Ren1, Mrap), cell proliferation 
(Fgfrl1, Impdh1) and apoptosis (Cidea, Casp12, Clu, Trib3, Elmo1). The patterns of change 
for the selected genes were broadly similar for microarray and qPCR methods (Figure 1D). 
Signalling Genes 
Figures 2a and 2b show heat maps of genes implicated in signal transduction that are up- and 
down-regulated by ACTH treatment (P < 0.01). A cluster analysis of signalling genes with 
Pearson correlation coefficients ≥ 0.9 is shown in supplementary figure 1. In general, the 
expression patterns of up-regulated genes involved in signalling (figure 2A) were similar to 
that of the melanocortin receptor accessory protein, Mrap.  Cross-tabulation of Pearson 
correlation coefficents for the up-regulated cluster show all values ranged between 0.87 and 
0.98. The cluster includes GTPase genes (Rab2, Rab10, Rhod) and genes involved in protein 
kinase A activity (Prkara1, Prkar2b) and localisation (Akap2). Paradoxically, Pde8b was also 
upregulated.  Other genes in the up-regulated cluster were those for factors controlling 
transcription (Creb312, Nr5a1), cell proliferation and hypertrophy (Rras2, Cdkn1a, Rcc2, 
Igflr, Shmt1) and several genes like Prkcd, Srxn1, Stx11 and Inha with known but ill-defined 
links to steroidogenesis. The function of others (Gucalb, Fam161a) have yet to be defined. 
Analysis of down-regulated signalling genes (figure 2B) suggest secondary events linked to 
aldosterone/zona glomerulosa functions (Rgs4, Kcnk1, Camkk1, Shh and Prkg2), neuronal/ 
adrenal medulla tissue (Insm1, Rgs11 and Kcnq2) or glucocorticoid activity (Irs1, Atp2b1 and 
Scn3b).  
Cholesterol supply 
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Figure 3A shows the effects of ACTH on oil red O staining suggesting a depletion of 
cholesterol ester droplets in the zona fasciculata. Microarray data indicated that genes 
involved in: (i) de novo cholesterol synthesis from acetyl CoA (Figure 3B); (ii) promoting 
cholesterol uptake from the circulation (Figure 3C); (iii) intracellular cholesterol mobilisation 
and trafficking and uptake of cholesterol into mitochondria (Figure 3D); (v) disposal of free 
cholesterol (Figure 3E), were all affected by ACTH treatment. Genes involved in cholesterol 
synthesis included those encoding HMG CoA reductase (Hmgcr) and also squalene 
epoxidase (Sqle) and post-lanosterol enzymes. In keeping with studies demonstrating that 
cholesterol for steroidogenesis is also derived from the circulation, genes encoding 
lipoprotein receptors and related proteins that are involved in cholesterol uptake from the 
circulation were increased.  Intracellular cholesterol is trafficked to mitochondria (Npc1, 
Osbpl6 are upregulated). Genes implicated in the mitochondrial uptake of cholesterol (a rate 
limiting step in steroidogenesis) were significantly upregulated too although changes in the 
expression of the key gene, Star (1.3 fold), was modest. Other than for immediate 
steroidogenesis, cholesterol may be stored or disposed. Storage as esters is mediated by 
transferase enzymes and requires a supply of lipid as well as cholesterol. Acat1 and Acat2 
(Figure 3E) and a wide range of genes involved in fatty acid synthesis (Supplementary Figure 
2) were downregulated. These changes are consistent with reduced oil red O staining. 
 
Genes affecting cholesterol disposal but not directly involved in steroidogenesis were also 
down-regulated by ACTH. Cyp27a1, Cyp7b1, Hsd3b7 genes mediate cholesterol 
hydroxylation and subsequent isomerase reactions. Overall control of the enzymes and 
receptors involved in cholesterol synthesis, uptake and metabolism is normally mediated by 
transcription factors FXR and SREBF1 which in turn are regulated by cholesterol sensing 
Insig proteins and intracellular sterol levels.  Nr1h4 (Fxr), Serbf1 and Insig1 genes were all 
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downregulated. Furthermore, upregulated genes implicated in cholesterol synthesis and 
uptake cluster together (Supplementary Figure 3). Conversely down-regulated genes 
associated with cholesterol disposal and lipid biosynthesis form a separate larger cluster. 
 
It is notable, that genes encoding enzymes that metabolise steroids were also affected. 
Akr1c18, which encodes a progesterone 20α hydroxysteroid dehydrogenase enzyme, was 
switched on in ACTH-treated adrenals (>80 fold) and expression of Srd5a1 and 2, which 
encode 5α steroid reductase enzymes, were reduced (1.6 and 5.4-fold respectively).  
Adrenal Size 
Cell Hypertrophy: Part of the ACTH-induced increase in adrenal mass is due to 
adrenocortical cell hypertrophy. The cross-sectional area of zona fasciculata cells, the main 
cell type of the cortex, was >2 fold greater but cells of other cortical zones were also 
increased (figure 4A & B). Medullary cell size was not affected. The expression of 
representative genes potentially implicated in cell hypertrophy are shown in figure 4C and 
include factors affecting growth, cell cycle, transcription and protein synthesis.  
 
Cell Hyperplasia: Figures 5A & B show the effects of ACTH on BrdU incorporation and 
Ki67 positive cells in the adrenal cortex. Labelled cells are located predominantly in the 
outermost region of the gland. BrdU was incorporated cumulatively over the entire period of 
infusion whereas Ki67-labelling identified only those cells in S-phase at the time of sacrifice. 
Immunohistochemistry identified approximately ten times more BrdU-positive than Ki67 -
positive cells (Figure 5B). Interestingly, ACTH increased the numbers of BrdU- and Ki67-
positive cells to a similar degree indicating that proliferative effects were sustained 
throughout the period of treatment. Increases in cell proliferation were matched by expression 
of genes associated with various aspects of cell division (Figure 5C). 
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Apoptosis: The net effect of ACTH on adrenocortical volume may involve a decrease in cell 
death as well as increases in cell hyperplasia and hypertrophy (figure 6A & B). Figure 6C and 
supplementary Figure 4 show the decreased expression of genes with a pattern similar to that 
of a key apoptotic gene,Casp12, and include histocompatibility factors and components of the 
complement system.  
 
Cluster analysis of genes linked to cell size and turnover (supplementary Figure 5) shows 
upregulated and downregulated genes. Within the upregulated cluster were overlapping genes 
associated with hypertrophy and hyperplasia. I 
It is notable that genes associated with cell proliferation were more tightly clustered (Tk1, 
Mki67, Cdc2a). Genes in the downregulated cluster are associated with apoptosis 
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Discussion  
An infusion of ACTH was used to model molecular and morphological changes in the mouse 
adrenal gland that contribute to long term steroidogenic control. Previously we have reported 
pathophysiological responses to this treatment, including raised urinary corticosterone to 
levels which are outwith normal circadian rhythms, thymic involution, hypertension and fluid 
and electrolyte imbalance, that suggest it represents a model of ACTH-dependent Cushings 
(Dunbar et al. 2010). The central part of the current study is a microarray analysis of adrenal 
mRNA expression which established that large numbers of genes were up- and down-
regulated indicating that adaptive genomic responses were far wider than might be 
anticipated from known acute changes in cell signalling and steroidogenesis. Closer analysis 
of clusters of changes in gene expression indicate that mechanisms are invoked with 
significant consequences for the continuing supply of steroid hormone substrate (cholesterol), 
for adrenocortical cell kinetics, for adrenocortical cell hypertrophy and for processes that 
might compensate excess glucocorticoid hormone. Genes encoding signalling factors that are 
responsible for these functional changes were also noted.   
 
The obligatory role for cholesterol in steroidogenesis and the factors and genetic diseases 
involving cholesterol metabolism which affect steroidogenesis are well recognised and have 
been reviewed extensively (Kraemer 2007; Miller and Bose 2011). Sustained high 
corticosterone output requires continuing cholesterol supply rather than mobilisation of extant 
stores.  This need is met by de novo synthesis and by uptake from the circulation. Genes 
encoding enzymes involved in cholesterol synthesis, including Hmgcr, Sqle, Scd5, Hsd17b7, 
Dhcr7, are up-regulated. It should be noted however that enzymes encoded by these genes 
and other enzymes in cholesterol biosynthesis are also regulated non-genomically and are 
subject to post-translational modification with activities controlled by kinases and various 
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sterols (Sharpe and Brown 2013). It is perhaps significant that Insig1 that encodes a 
cholesterol sensor, is down-regulated more than twofold by ACTH. Insig1 reduces 
transcriptional activity and promotes degradation of key enzymes involved in cholesterol 
biosynthesis like HMG-CoA reductase (Dong, et al. 2012).  
 
Adrenal cholesterol is also provided by circulating lipoproteins: predominantly LDL in 
humans via LDL receptors (Ldlr) and HDL in rodents via scavenger receptors (Scarb1) 
(Gwynne and Strauss 1982; Kraemer 2007; Rigotti, et al. 1996). ACTH increased expression 
of both Ldlr and Scarb1 as well as Ldlrap1 which facilitates LDL uptake. Apoe, which is also 
known to affect LDL receptor activity and is highly expressed specifically in the adrenal 
cortex, was not affected. This contrasts with previous reports on apolipoprotein E protein and 
mRNA levels (Cheng, et al. 1998; Prack, et al. 1991) . However, the gene Lrp8 which 
encodes a receptor for ApoE was upregulated as was Vldlr; both genes have been associated 
with the reelin signalling system which controls neural development and plasticity (Herz and 
Chen 2006) suggesting an alternative adrenal function. Similarly, Hdlbp, although increased 
by ACTH treatment and with an affinity for HDL (Fidge 1999), is also known as vigilin, an 
RNA binding protein with wider functions that might be independent of steroidogenesis 
(Mobin, et al. 2016) .  
 
Cholesterol from circulating lipoproteins is taken up in the form of esters requiring hydrolysis 
to render free cholesterol for steroidogenesis. Two genes encoding adrenal cholesterol 
esterases have been identified: hormone sensitive lipase (Lipe) (Kraemer 2007) and more 
recently neutral cholesterol ester hydrolase (Nceh1) (Ohta, et al. 2011). Control of hormone 
sensitive lipase activity may be post-translational (Yeaman 2004); Lipe expression is not 
significantly affected in the present study (-1.67, P = 0.1). In contrast, Nceh1 is modestly 
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increased by ACTH treatment (1.82, P<0.0001). It is notable that genes encoding factors 
required for intracellular cholesterol trafficking (Npc1, Stx11) (Li, et al. 2016; Lin, et al. 
2016) were also up-regulated.  
 
Under normal conditions, excess cholesterol is stored as esters in lipid droplets. As evidenced 
previously (Cheng et al. 1998; Thorngate et al. 2002)  and here by oil red O staining, the zona 
fasciculata cells of ACTH-treated mice are deplete of lipid. A pattern of reduced expression 
of genes involved in cholesterol and lipid metabolism is consistent with this depletion. Plin4 
(perilipin 4, a component of the droplet coat) (Kraemer, et al. 2013) is down-regulated as are 
Acat1 and 2, the transferases that esterify cholesterol. However, these transferases are also 
known to be allosterically activated by sterols (Rogers, et al. 2015). In addition, many genes 
implicated in the biosynthesis of the lipids which are co-substrates in cholesterol ester 
synthesis are down-regulated, implying that triglycerides are normally produced locally to 
maintain cholesterol ester reserves (Supplementary Figure 2). 
 
A further way of optimising cholesterol supply is to limit non-steroidogenic routes of 
metabolism. Excretion of cholesterol is via hepatic bile acid synthesis and although the 
adrenal does not produce significant amounts of bile, genes encoding three genes in bile 
synthesis are down-regulated as is Fxr, a key transcription factor regulating the bile pathway 
(Russell 2009). Stard10 which binds phosphatidyl choline and is involved in bile acid 
metabolism, is also down-regulated (Alpy and Tomasetto 2014).  The work of Schroeder et al 
(Schroeder, et al. 2010) has implicated sterol carrier protein-2 (Scp2) and caveolin-1 (Cav1) 
as factors in liver controlling the intracellular distribution, efflux and esterification of 
cholesterol. It is significant therefore that ACTH downregulated both Scp2 (-1.62 fold, P 
<0.001) and Cav1 (-2.37 fold, P <0.0001) expression. 
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The first step in steroidogenesis is the mitochondrial side chain cleavage of cholesterol to 
produce pregnenolone. Cleavage activity is determined by cholesterol uptake across the 
mitochondrial membrane. Papadopoulos and colleagues have suggested that this involves a 
complex of five proteins termed a transduceosome (Liu, et al. 2006). Although this 
hypothesis is controversial (Selvaraj, et al. 2016),  of the genes encoding these five proteins, 
Vdac1 and Prkar1a are upregulated two fold (P<0.001), Star and Acbd3 are slightly increased 
(1.2 fold, P<0.01) and Tspo (peripheral benzodiazepine receptor) expression is unaffected. 
 
The relative change in genes encoding steroidogenic enzymes is modest (<1.3 fold) 
reaffirming studies that show cholesterol supply is critical in maintaining high corticosteroid 
output when enzyme expression is non-limiting. However, it is notable that ACTH has 
profound effects on other genes affecting steroid metabolism. Akr1c18, which encodes a 20α 
hydroxysteroid dehydrogenase enzyme, was switched on in ACTH-treated adrenals (>80 
fold). This is consistent with observations in sheep where circulating levels of 
dihydroxyprogesterone were increased in ACTH-induced hypertension (Butkus et al. 1985). 
Previous studies in mouse indicate that adrenal Akrc18 expression is normally high in 
prepubertal and low in adult males (Hershkovitz, et al. 2007). In contrast expression of Sd5a2 
that encode a 5α steroid reductase, which is normally high in the male mouse adrenal gland 
(Luu-The et al. 2005), was decreased more than 5-fold by ACTH. In general, the activity of 
these enzymes controls the availability of intermediates in the corticosteroid pathway thereby 
affecting throughput to biologically active hormonal end products. 
 
A major contribution to steroidogenic capacity is the marked threefold increase in adrenal 
mass. The morphology of adrenals from ACTH-treated mice indicate this is due to expansion 
Page 15 of 32
of the cortex rather than the medulla and is a function of both the size and numbers of 
parenchymal cells. Histology shows that cell hypertrophy is predominantly a feature of the 
zona fasciculata. The twofold increase in cross-sectional area with ACTH treatment is 
perhaps an underestimate since volume expansion is offset by depletion of lipid droplets. 
Increased expression of Cdkn1a, a marker of cell cycle arrest, suggested cell cycle 
progression beyond the G1 stage is inhibited in some cells. The close correlation of Cdkn1a 
expression with other genes (correlation coefficient >0.9, P<0.0001) reflects changes in 
growth and de novo protein. Cdkn1c, a gene known to affect adrenal cell turnover in 
embryonic life (Nagahama, et al. 2001), was also increased (4.12 fold) but with a pattern of 
change that did not strongly correlate with that of Cdkn1a (r = 0.62). 
 
BrdU and Ki67 immunostaining demonstrated ACTH caused a sustained stimulation of cell 
division which appeared to be initiated in a subcapsular region of the gland with displacement 
of newly divided cells inwards (Chang et al. 2013). The majority of hypertrophied cells 
throughout the cortex were not immunostained suggesting that increased cell size is 
independent of mitosis. In line with Ki67 staining, expression of Mki67 was also increased as 
were a number of genes linked to cell proliferation and the cell cycle. Tk1, encoding 
thymidine kinase, another established marker of proliferation, was increased 2.25 fold (P < 
0.0001). As with genes controlling cell hypertrophy, expression of genes associated with 
proliferation were closely clustered. 
 
Cell number is determined by cell death (apoptosis) as well as division. The term apoptosis 
was first used in the seminal work of Kerr et al (Kerr, et al. 1972) to describe programmed 
cell death in several experimental models including the effects of ACTH withdrawal on the 
rat adrenal cortex. Not surprisingly, ACTH infusion in the present experiment had anti-
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apoptotic effects which were linked to decreased expression of genes like Casp12. These 
genes include histocompatibility factors, which previous studies have shown are expressed in 
inner regions of the cortex with a role in apoptosis (Wolkersdorfer, et al. 1996). Similarly, 
various components of complement activation that have been shown to play a role in the 
clearance of apoptotic cells (albeit in non-adrenal cells (Ogden and Elkon 2006)) were 
decreased. It should be stressed, however, that the level of apoptosis in a normal gland is low 
so that an ACTH-induced reduction in apoptosis may be difficult to detect, particularly if cell 
clearance is efficient (Carsia, et al. 1996). Nevertheless, Tunel staining in the present study 
showed a fivefold decrease with ACTH treatment. This is perhaps an overestimate given that 
the number of apoptotic cells is expressed relative to cross sectional area of the cortex and the 
cross-sectional area of cells from ACTH-treated adrenals is up to two times greater than 
controls. 
 
The diversity of cellular effects underlying the response to chronic ACTH treatment is 
reflected in the range of genes involved in signalling.  ACTH receptor regulation of adrenal 
activity is mediated through the cyclic AMP cascade (Gallo-Payet 2016) but few of the genes 
involved are affected. Adenylate cyclase isoforms are generally down-regulated and Pde8b, 
which is negatively associated with steroidogenic activity (Horvath, et al. 2008), was up-
regulated by ACTH treatment. Genes involved in protein kinase A activity which are mutated 
in some patients with ACTH-independent Cushings (Calebiro et al. 2015) were up-regulated 
as was the protein kinase A anchor protein Akap2. The upregulated cluster was enriched with 
genes implicated in processes downstream of the cyclic AMP cascade including genes for 
transcription factors (Nr5a1, Creb3l2), for cell proliferation and hypertrophy (Rras2, Cdkn1a, 
Rrcc2, Igflr, Shmt1) and for snare proteins (Stx11). Genes like Prkcd, Srxn1 and Inha are 
known to be involved in steroidogenic control (Brizuela, et al. 2006; Hofland and de Jong 
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2012; Kil, et al. 2012) whereas the function of others (Gucalb, Fam161a) have yet to be 
defined. 
 
Analysis of down-regulated signalling genes suggest secondary events. For example, Rgs4, 
Kcnk1, Camkk1, Shh and  Prkg2 have been linked to aldosterone/zona glomerulosa functions 
(Azizan, et al. 2012; Beuschlein, et al. 2013; Nanba, et al. 2015; Romero, et al. 2007; 
Spiessberger, et al. 2009; Walczak, et al. 2014), Insm1, Rgs11 and Kcnq2 are associated with 
neuronal/ adrenal medulla tissue (Anderson, et al. 2009; Etxeberria, et al. 2008; Wildner, et 
al. 2008) and expression of Irs1, Atp2b1 and Scn3b are controlled by glucocorticoids 
(Bhargava, et al. 2002; Fahmi, et al. 2004; Giorgino, et al. 1993; Turnbow, et al. 1994). 
 
In summary, a large number of adrenal genes are differentially affected by chronic ACTH 
treatment. Upregulated genes include those implicated in cell division and cell hypertrophy as 
well as those promoting cholesterol supply from de novo synthesis and uptake from the 
circulation. Downregulated genes are those involved in apoptosis, intracellular storage of 
cholesterol esters and non-steroidogenic metabolism of cholesterol. Preliminary observations 
indicate that genes controlling each of these different processes are co-ordinately regulated. 
Theoretically, this information could be used to target genes to manipulate glucocorticoid 
output or ACTH responsiveness. For example, the adverse effects of glucocorticoid 
hormones could be ameliorated in patients with Cushing’s disease due to excess pituitary 
ACTH or Cushing’s Syndrome caused by ectopic ACTH production,  It is important, 
however, to reiterate that many genes that are transcriptionally regulated by ACTH encode 
factors which are subject to non-genomic control. Finally, excessively high glucocorticoid 
hormone levels may, secondarily, affect gene expression in the zona glomerulosa and the 
adrenal medulla with consequences for aldosterone and catecholamine synthesis.                                                           
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Figure Legends 
Figure 1: ACTH infusion causes adrenal hypertrophy (A), increased corticosterone levels (B) 
and altered expression of gene transcripts (C & D). Values shown in A and B are mean values 
±SEM, n = 6. Microarray values (grey bars) are compared with RT-PCR values (black bars) 
for a range of up and down regulated genes (D). 
 
Figure 2. Heat maps showing expression genes involved in cell signalling that are up-
regulated (A) and down-regulated (B) by ACTH. Each square represents gene expression of a 
single sample. Shades of blue and red indicate levels of expression below and above 
normalised values for individual genes.  
 
Figure 3: ACTH infusion causes depletion of lipid droplets in adrenal cortex (A) and up-
regulation of gene transcripts associated with cholesterol biosynthesis (B), the cellular uptake 
of cholesterol (C) and the intracellular distribution of cholesterol (E). Down-regulated 
transcripts associated with non-steroidogenic routes of cholesterol metabolism are shown (D). 
Values are means ± SEM of n =5 (control) and 6 (ACTH) adrenal glands. 
 
Figure 4: ACTH infusion caused adrenocortical cell hypertrophy (A & B) and increased 
expression of transcripts associated with cell growth (C). (A) shows representative H&E 
stained sections with bar indicating magnification (100µm). (B) shows cross sectional area of 
cells in zona glomerulosa (ZG), outer zona fasciculata (OZF), inner zona fasciculata (IZF) 
and medulla (MED) regions of the gland. Values are means ± SEM of n =6 (control) and 6 
(ACTH) adrenal glands. (C) shows increased expression of genes associated with cell size. 
 
Figure 5: ACTH infusion increased adrenocortical cell proliferation (A & B) and the 
expression of gene transcripts associated with cell division (C). Sections of adrenal gland 
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from control and ACTH were dual immunostained (A) for Ki67 (brown nuclei) and 
bromodeoxyuridine (purple nuclei) and analysed for numbers of positive nuclei (B). Values 
are means ± SEM of n =6 (control) and 6 (ACTH) adrenal glands; * - P<0.01, ** - P < 
0.001).  ACTH-induced fold changes in gene transcripts associated with cell proliferation are 
shown in (C). 
 
Figure 6: ACTH treatment reduced Tunel staining in the adrenal cortex (A). Numbers of 
apoptotic cells corrected for cross-sectional area of cortex  (B) were significantly reduced (P 
<0.001). Values shown are means ± SEM of n = 4 control and ACTH-treated adrenals. 
ACTH decreased expression (fold change) associated with apoptosis are shown in (C) (see 




Supplementary Figure 1: Cluster analysis of adrenal signalling genes that are controlled by 
ACTH. Lines represent Pearson correlation coefficients for associations between genes that 
are ≥ 0.9. The cluster on the left comprises up-regulated genes; the cluster on the right are 
down-regulated genes. 
 
Supplementary Figure 2: Heat map showing genes associated with the control of lipid 
biosynthesis which are down-regulated by ACTH treatment. Each square represents gene 
expression of a single sample. Shades of blue and red indicate levels of expression below and 
above normalised values for individual genes. 
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Supplementary figure 3: Cluster analysis of adrenal genes controlled by ACTH that are 
implicated in sterol/lipid metabolism.  Lines represent Pearson correlation coefficients 
between genes that are ≥ 0.9. The cluster on the upper left comprises up-regulated genes 
including those involved in cholesterol biosynthesis (eg Sqle, Hsd17b7), uptake from the 
circulation (eg Scarb1) and intracellular trafficking (eg Npc1, Vdac1). The cluster on the 
lower right are down-regulated genes involved in cholesterol storage (eg Acat1, Plin4) and 
disposal (Cyp27a1) and lipid biosynthesis (eg Adipoq, Ppara, Fasn). 
 
Supplementary Figure 4: Heat map showing the effects of ACTH treatment on down-
regulated genes associated with apoptosis. Each square represents gene expression of a single 
sample. Shades of blue and red indicate levels of expression below and above normalised 
values for individual genes. 
 
Supplementary Figure 5:  Cluster analysis of adrenal genes modulated by ACTH treatment 
that are associated with cell hyperplasia, hypertrophy and apoptosis. Lines represent Pearson 
correlation coefficients between genes that are ≥ 0.9. The cluster on the left comprises up-
regulated genes that are associated with cell hyperplasia and hypertrophy: note the genes in 
grey include Mki67, Tk1 and Cdc2a that are involved in cell proliferation. The genes in 
yellow on the right are down-regulated genes including Casp12 and various 
histocompatibility and complement system genes that are associated with apoptosis. 
 
Supplementary Table1: Genes of Interest 
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